Introduction
Specific chromosomal translocations are a genetic hallmark of lymphoid malignancies in nonHodgkin`s lymphomas (NHL). The immunoglobulin gene loci are involved in most of these translocations in B cell NHL, suggesting that mistaken maturation of the immunoglobulin genes may contribute to lymphoma formation (1, 2) . During B cell development the immunoglobulin genes are altered by three distinct mechanisms: In B lymphoblasts, V(D)J joining rearranges the immunoglobulin-gene variable (V), diversity (D) and joining (J) segments to produce the primary antibody repertoire; this well defined process is mediated by the recombination activating genes 1 and 2 (3, 4) . After antigen encounter, an effective secondary antibody response is achieved by somatic hypermutations (SHM) of the variable region exons and by class switch recombination (CSR) that replaces the µ constant region with one of the downstream located constant regions (5, 6) . Activation-induced cytidine deaminase (AID) is indispensable for SHM, CSR and immunoglobulin gene conversion in B cells (7) (8) (9) (10) . AID is a close homologue of APOBEC-1, the catalytic subunit of the apo B mRNA editing-complex; AID and APOBEC-1 are located in tandem on chromosome 12 and apparently have arisen by gene duplication (11) (12) (13) (14) . APOBEC-1 is an RNA-dependent cytidine deaminase that specifically deaminates C 6666 in the apo B mRNA together with the APOBEC-1 stimulating protein (12, (15) (16) (17) (18) . In AID deficient mice, both SHM and CSR are completely abolished leading to a severe defect of the humoral immune response (8) . In human patients with the autosomal recessive form of the hyper-IgM syndrome (HIGM2) various mutations in the human AID gene have been found that cripple AID function (7) . In these patients not only CSR is absent, but also SHM is strongly reduced (7) . In fibroblasts, the expression of AID is sufficient to mediate CSR of an artificial switch substrate and SHM in an actively transcribed artificial gene substrate (19, 20) . Expression of AID in E. coli leads to a For personal use only. on . by guest www.bloodjournal.org From Activation-induced deaminase in B cell non-Hodgkin`s lymphomas 4 hypermutator phenotype with nucleotide transitions at dC/dG in a context dependent manner (21) .
Moreover, expression of a bacteriophage derived inhibitor protein of uracil-DNA glycosylase in chicken DT40 cells that lack the repair gene XRCC2 shifts the pattern of SHM from predominantly transversions to transitions (22) . These recent results indicate that AID may simply act by deamination of cytidines in the DNA (21, 22) .
As APOBEC-1 transgenic animals develop hepatocellular carcinomas (23) , we reasoned that also AID may be a potential oncogene. Here we demonstrate that AID is constitutively expressed in follicular lymphomas (FL) and diffuse large B cell lymphomas (DLBCL), while in normal B cell development the expression of AID is highly regulated and restricted to germinal center B cells. This constitutive expression of AID may contribute to NHL formation.
Methods

Isolation of B-cell populations from human tonsils:
Human non-malignant tonsils were obtained with written consent from adult patients undergoing tonsillectomy. The tonsil specimens were minced and the single cell suspension was filtered through a 100 µm filter (Filcon, DAKO, Denmark). Lymphocytes were isolated by gradient centrifugation using Ficoll-Paque medium (Amersham Pharmacia Biotech, Uppsala, Sweden). Activation-induced deaminase in B cell non-Hodgkin`s lymphomas 6 were purchased from DAKO (Hamburg, Germany), except for CD20, Ki-B3 and Ki-S5 which had been generated in the Lymphoma Registry Kiel. polyacrylamide sequencing gels was performed as described (25, 26) .
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Activation-induced deaminase in B cell non-Hodgkin`s lymphomas 9 Analysis of somatic hypermutation of the variable region of the immunoglobulin heavy chain gene: The recombined V(D)J segments of the IgH transcripts of the lymphoma specimens were amplified from the respective cDNA pools by PCR using a set of degenerate oligonucleotides exactly as described (27) .
Determination of immunoglobulin heavy and light chain expression:
Immunglobulin heavy chain and light chain expression was determined by standard immunohistochemistry using antibodies against kappa, lambda, IgM, IgG, IgD, IgE and IgA as described (28) . 1 ).
Results
Expression of AID mRNA in human germinal
Naive human IgM + B cells isolated from human tonsils were cultivated for up to 8 days in the presence of IL-4 and plasma membranes of Sf21 cells that had been infected with a CD40-L expressing baculovirus. AID mRNA was strongly induced between day 2 and 3 ( Fig. 2 A) . At day 4, the levels of AID mRNA strongly decreased (Fig. 2 A) . The mRNA of bcl-6 decreased around day 4 and was hardly detectable from day 5 to day 8 ( Fig. 2A) . In contrast, the mRNA of
blimp-1 was strongly induced around day 5 (Fig. 2 A) . The mRNA expression of AID, bcl-6 and blimp-1 in these cells was quantitated by real-time PCR (Fig. 2 B) . The increase of AID mRNA at day 3 was approximately 40-fold in comparison to the AID mRNA levels of naive B lymphocytes at day 1 (Fig. 2 B) . At day 0, AID mRNA could not be detected by real time RT-PCR. From day 3 to day 4, the AID mRNA decreased by more than 80% (Fig. 2 B) . The mRNA of bcl-6 steeply decreased from day 4 to day 5, while the mRNA of blimp-1 increased approximately 50-fold between day 4 and day 6 (Fig. 2 B) . When the naive human IgM + B cells
were cultivated in the presence of CD40-L without IL-4, the AID mRNA of AID was induced much later, at day 4 instead of day, and this induction was far less pronounced (data not shown). products of AID mRNA were generated in all cases of FL (n=5) and in all cases of DLBCL (n=13). In MALT-lymphoma (n=8), in IC (n=8) and in B-CLL (n=5), a heterogeneous expression pattern was found for AID mRNA, with strong expression in some and absence of expression in other cases. c-myc mRNA was strongly amplified from DLBCL, while blimp-1 was most abundantly expressed in IC, MM and, to less extent, in B-CLL (Fig. 3 ). Bcl-6 was strongly expressed in IC (Fig. 3) . In normal human lymph nodes (n=4), AID mRNA could only be detected by nested RT-PCR, but not by the our conventional RT-PCR, indicating that AID is expressed in normal lymphatic tissues at much lower levels as compared to the germinal center B-NHLs (data not shown).
Expression
In all AID expressing lymphomas the full length AID mRNA is the most abundant splice form (Fig. 4) . Alternative splicing generates three additional AID mRNA variants. In splice variant 1 (sv1), the intron between exon 3 and exon 4 is not spliced extending the open reading
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In splice variant 3 (sv3), an short neo-exon located in intron 3 is used while exon 3 and exon 4 are excluded (Fig. 4) . This spliced variant encodes a truncated peptide consisting of the aminoterminus and carboxyterminus of AID linked by 20 amino acid residues encoded by the neo-exon 3 (Fig. 4) . In FL, sv2 was the second minor splice variant, while in MALT-lymphoma, sv1 was the second minor variant (Fig. 4 A) . In MALT-lymphoma, both sv1 and sv3 are expressed, while in FL and in DLBCL, only sv3 could be found (Fig. 4) . Sequencing did not detect points mutations in AID full length cDNAs from FLs (n=3), DLBCL (n=3) and MALTlymphomas (n=3).
The expression of AID mRNA in human B cell non-Hodgkin`s lymphoma was directly quantitated by ribonuclease protection analysis (RPA). For these experiments an AID antisense RNA probe complementary to exon 1 and 2 was used. Therefore, full length AID as well as the mRNA variants sv1 and sv2 protect an identical fragment of 222 nucleotides. The expected protected fragment of 222 nucleotides was observed with the highest intensity in MALT, followed by FC and DLBCL (Fig. 5) . Quantification of AID mRNA based on the expression of -actin mRNA revealed that in this particular MALT-lymphoma the AID mRNA levels were approximately tenfold higher than in FL. In the samples of B-CLL and of immunocytoma used in this experiment, no AID mRNA was detectable by RPA (Fig. 5) .
AID mRNA expression, somatic hypermutations and class switch recombination in human
B cell non-Hodgkin´s lymphomas: Next, we studied somatic hypermutation (SHM) of the recombined V(D)J segment and determined the subtype of the constant region of the immunoglobulin heavy chain (IgH) gene in MCL (n=3), in FL (n=3), in DLBCL (n=3) and in B-CLL (n=3) in correlation to the expression of AID mRNA (Fig. 6) . In MCL, no AID mRNA is expressed, no somatic hypermutation of the variable region is detectable and the µ constant region of the IgH gene is expressed (Fig. 6) . In contrast, in FL and in DLBCL that both express
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Activation-induced deaminase in B cell non-Hodgkin`s lymphomas 12 AID mRNA, the variable region of the IgH gene is hypermutated (Fig. 6) . In most cases of FL, the IgH gene locus has not undergone isotype class switch recombination (CSR), and mainly IgM is expressed (Fig. 6) . In contrast, in most cases of DLBCL, CSR of the IgH gene has occurred and IgG is expressed (Fig. 6 ). In the B-CLLs investigated, CSR had not occurred and somatic hypermutation was either absent or very low (Fig. 6 ).
As not all DLBCL are thought to be derived from germinal center cells, we analyzed a total of 13 cases of DLBCL and stratified them according to their expression of CD10 as detected by immunohistochemistry that can be used to discriminate the germinal center B cell-like type of DLBCL from the activated B cell-like type (29) . Five of these DLBCL were positive for CD10, and eight were negative (Table 1) . AID mRNA was detected in all five CD10 positive and all eight CD10 negative DLBCLs ( Table 1) . Three of the CD10 positive DLBCLs had developed from confirmed FLs, while none of the CD10 negative cases had progressed from a FL (Table 1) .
SHM were detected in 3 out of 3 cases of the CD10 positive DLBCL of which we sequenced the variable region of the immunoglobulin heavy chain gene, and in 5 out of 5 of the CD10 negative DLBCLs ( Table 1 ).
The expression of AID and blimp-1 was also studied in 7 MALT-lymphomas and in 7 immunocytomas (Fig. 7) . In the MALT-lymphomas, a rather great variation of AID mRNA expression was observed with relatively high AID expression in three, and low or no expression of AID mRNA in five cases (Fig. 7) . The expression of blimp-1 is inversely correlated to the expression of AID in MALT lymphomas, and to less extent, in immunocytomas (Fig. 7) . Thus, the lymphomas with high level expression of blimp-1 demonstrated less AID mRNA, and high level expression of AID mRNA was linked to low amounts of blimp-1 (Fig. 7) . In the MALT lymphomas, SHM was present in all cases with the exception of two cases in which no IgH transcripts could be detected. Interestingly, the MALT-lymphoma with the high level expression of AID mRNA (lane 2 and Fig. 5 ) demonstrated only low levels of SHM (3,2% base changes in the variable region), and expressed IgM (Fig. 7) . While AID mRNA was absent in two and expressed in five ICs, SHM and CSR could not be detected in the ICs with the exception of one
Activation-induced deaminase in B cell non-Hodgkin`s lymphomas 13 sample (lane 9) (Fig. 7) . Notably, this IC with low level SHM did not express AID, while the ICs with AID expression did not demonstrate SHM (Fig. 7) . Therefore, in MALT-lymphoma and in ICs no correlation of AID expression with the presence of SHM in the IgH variable regions is observed. In addition, AID expression was studied in the blood lymphocytes of 10 additional patients with B-CLL. In 7 of these patients, AID mRNA was detected in blood lymphocytes, while in the other 3 AID mRNA was undetectable (data not shown). As in IC, no correlation of AID expression and SHM was found in the blood lymphocytes of these 10 patients with B-CLL.
Discussion
This investigation demonstrates for the first time that AID is highly regulated in normal human germinal center B cells, namely the CD44 -centroblasts, but is constitutively expressed in FL and DLBCL. AID mRNA is absent in cALL, in MCL and in MM. In MALT-lymphoma, in IC and also in B-CLL, AID mRNA can be detected only in a subset of cases. Further studies with more patients will be required to investigate whether the expression of AID in these cases is associated with a different growth phenotype, a different response to treatment or even a different clinical outcome.
Recent studies have demonstrated the pivotal role of AID for the induction of both SHM and CSR that mark the transition of the primary humoral immune response to the secondary phase of a mature, highly specific antibody production (10, 30, 31) . The identification of AID enables to study these events at a molecular level. We started to investigate AID expression in normal human germinal center B cells and B cell NHLs as AID might be a pacemaker for lymphoma development and malignant progression. This assumption is supported by the finding of AID induced mutations in E. coli demonstrating that AID alone is sufficient to confer a mutator phenotype (21) . Moreover, aberrant hepatic overexpression of the AID homologue The expression of AID in DLBCL and FL was coincident with the occurrence of SHMs in the variable region exons of the IgH locus. On the contrary, the absence of AID expression in MCL was associated with a lack of both CSR and SHM. In DLBCL, the expression of AID is predictable for SHM and CSR and may become a molecular marker for these processes. AID 
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